MindfulGarden for Delirium
(RESPITE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called MindfulGarden to determine its effectiveness in aiding patients after heart surgery. The device displays calming nature images to potentially reduce the need for certain medications and improve recovery for those at risk of confusion or disorientation (delirium). Participants will be divided into two groups: one using MindfulGarden and the other receiving standard care. Ideal candidates for this trial are individuals planning to undergo open-heart surgery with a history of conditions such as stroke or cognitive issues. As an unphased trial, this study provides a unique opportunity to explore innovative recovery methods and contribute to advancing patient care.
Do I have to stop taking my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. It seems like you can continue your usual medications, but it's best to confirm with the trial coordinators.
What prior data suggests that the MindfulGarden device is safe for patients undergoing cardiac surgery?
Research has shown that MindfulGarden, a new device displaying calming nature images, has been tested on patients after surgery. One study found it reduced the need for extra medications for delirium, a common post-surgery state of confusion. This suggests the device is gentle on patients. No reports have directly linked negative side effects to using MindfulGarden. As it is not a drug, it likely poses fewer risks than medications. Overall, existing evidence indicates that MindfulGarden is safe for patients recovering from heart surgery.12345
Why are researchers excited about this trial?
Researchers are excited about the MindfulGarden intervention because it offers an innovative approach to managing delirium through a non-pharmacological method. Unlike standard treatments for delirium in post-operative cardiac surgery patients, which often rely on medications like antipsychotics and sedatives, MindfulGarden uses immersive digital technology to create a calming environment. This method aims to reduce stress and confusion by engaging patients with soothing visuals and sounds. By potentially minimizing the need for medication, MindfulGarden could decrease side effects and improve recovery experiences.
What evidence suggests that the MindfulGarden device is effective for reducing delirium in cardiac surgery patients?
Research has shown that the MindfulGarden device, which participants in this trial may receive, can help reduce the need for extra medications for confusion and restlessness. In one study, patients who used MindfulGarden needed fewer medications for these issues. The device uses soothing visuals that may ease confusion after surgery. Early findings suggest it could also improve overall recovery for patients. While more research is needed, these initial results are promising for those undergoing heart surgery.12356
Who Is on the Research Team?
Alana Flexman, MD MBA
Principal Investigator
University of British Columbia
Are You a Good Fit for This Trial?
This trial is for patients undergoing cardiac surgery who may experience postoperative issues like delirium or agitation. Participants will receive standard care, but some will also use a new device called MindfulGarden that shows responsive nature imagery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive routine post-operative management and are randomized to either receive the MindfulGarden device or standard care
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of delirium, anxiety, and recovery quality
What Are the Treatments Tested in This Trial?
Interventions
- MindfulGarden
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Canadian Anesthesiologists' Society
Collaborator